Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context.

Berg CD.

Acta Oncol. 2011 Jun;50 Suppl 1:12-7. doi: 10.3109/0284186X.2010.531283. Review.

PMID:
21604935
2.
3.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
4.

Screening for prostate cancer: have we resolved the controversy?

Zhu X, Roobol MJ, Schröder FH.

Curr Opin Support Palliat Care. 2010 Sep;4(3):121-6. doi: 10.1097/SPC.0b013e32833abc21. Review.

PMID:
20489646
5.

Update on PSA testing.

Gonzalgo ML, Carter HB.

J Natl Compr Canc Netw. 2007 Aug;5(7):737-42. Review.

PMID:
17692178
6.

[Early detection of cancer of the prostate. Pros and cons].

Hoesl CE, Altwein JE.

MMW Fortschr Med. 2005 Apr 7;147(14):32, 34-6. Review. German.

PMID:
15887681
7.

Update on screening and early detection of prostate cancer.

Otto SJ, de Koning HJ.

Curr Opin Urol. 2004 May;14(3):151-6. Review.

PMID:
15069305
8.

Prostate cancer: who to screen, and what the results mean.

Small EJ.

Geriatrics. 1993 Dec;48(12):28-30, 35-8. Review.

PMID:
7504646
9.

Screening for prostate cancer---the controversy continues, but can it be resolved?

Bul M, Schröder FH.

Acta Oncol. 2011 Jun;50 Suppl 1:4-11. doi: 10.3109/0284186X.2010.522197. Review.

PMID:
21604934
10.

The case for prostate cancer screening.

Andriole GL.

Semin Urol. 1993 May;11(2):50-3. Review.

PMID:
7689738
11.

Prostate-specific antigen kinetics in localized and advanced prostate cancer.

Fitzpatrick JM, Banu E, Oudard S.

BJU Int. 2009 Mar;103(5):578-87. doi: 10.1111/j.1464-410X.2009.08345.x. Epub 2009 Feb 6. Review.

12.

Prostate-specific antigen testing and prostate cancer screening.

Djavan B, Eckersberger E, Finkelstein J, Sadri H, Taneja SS, Lepor H.

Prim Care. 2010 Sep;37(3):441-59, vii. doi: 10.1016/j.pop.2010.05.001. Review.

PMID:
20705192
13.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK.

J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. Review.

14.

[Mass screening for prostate cancer--how to eliminate clinically insignificant cancer].

Imai K, Kubota H.

Gan To Kagaku Ryoho. 1998 May;25(6):809-12. Review. Japanese.

PMID:
9617317
15.

Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.

Ito K.

Int J Urol. 2009 May;16(5):458-64. doi: 10.1111/j.1442-2042.2009.02293.x. Epub 2009 Apr 1. Review.

16.

Prostate-specific antigen in screening of prostate cancer.

Chu TM.

J Clin Lab Anal. 1994;8(5):323-6. Review.

PMID:
7528795
17.
18.

Prostate cancer screening: more harm than good?

Lefevre ML.

Am Fam Physician. 1998 Aug;58(2):432-8. Review.

19.

Use and assessment of PSA in prostate cancer.

Gjertson CK, Albertsen PC.

Med Clin North Am. 2011 Jan;95(1):191-200. doi: 10.1016/j.mcna.2010.08.024. Review.

PMID:
21095422
20.

Screening for prostate cancer.

Brawer MK.

Semin Surg Oncol. 2000 Jan-Feb;18(1):29-36. Review.

PMID:
10617894

Supplemental Content

Support Center